收益预期修正

Search documents
PTC Inc. (PTC) Beats Q3 Earnings and Revenue Estimates
ZACKS· 2025-07-30 22:21
Group 1 - PTC Inc. reported quarterly earnings of $1.64 per share, exceeding the Zacks Consensus Estimate of $1.22 per share, and showing an increase from $0.98 per share a year ago, resulting in an earnings surprise of +34.43% [1][2] - The company achieved revenues of $643.94 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 10.57%, compared to $518.64 million in the same quarter last year [2] - PTC Inc. has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2][6] Group 2 - The stock has gained approximately 11.1% since the beginning of the year, outperforming the S&P 500's gain of 8.3% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4][7] - The current consensus EPS estimate for the upcoming quarter is $1.96 on revenues of $709.64 million, and for the current fiscal year, it is $6.09 on revenues of $2.49 billion [7] Group 3 - The Computer - Software industry, to which PTC Inc. belongs, is currently ranked in the top 21% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5][6]
Cadence Design Systems (CDNS) Q2 Earnings and Revenues Top Estimates
ZACKS· 2025-07-28 22:16
Core Viewpoint - Cadence Design Systems reported strong quarterly earnings, exceeding expectations and showing significant year-over-year growth in both earnings and revenues [1][3]. Financial Performance - The company achieved earnings of $1.65 per share, surpassing the Zacks Consensus Estimate of $1.57 per share, and up from $1.28 per share a year ago, representing a year-over-year increase of approximately 28.8% [1][2]. - Revenues for the quarter reached $1.28 billion, exceeding the Zacks Consensus Estimate by 1.33%, and up from $1.06 billion in the same quarter last year, indicating a year-over-year growth of about 20.8% [3]. Earnings Surprises - The earnings surprise for the latest quarter was +5.10%, following a previous surprise of +5.37% in the prior quarter [2]. - Cadence has consistently surpassed consensus EPS estimates over the last four quarters [2][3]. Stock Performance - Since the beginning of the year, Cadence shares have increased by approximately 10.6%, outperforming the S&P 500's gain of 8.6% [4]. Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.75, with expected revenues of $1.33 billion, and for the current fiscal year, the estimate is $6.77 on $5.2 billion in revenues [8]. - The Zacks Rank for Cadence is currently 4 (Sell), indicating expectations of underperformance in the near future, influenced by unfavorable estimate revisions prior to the earnings release [7]. Industry Context - The Computer - Software industry, to which Cadence belongs, is currently ranked in the top 15% of over 250 Zacks industries, suggesting a favorable environment for stocks within this sector [9].
Eagle Bancorp (EGBN) Reports Q2 Loss, Lags Revenue Estimates
ZACKS· 2025-07-23 22:41
Eagle Bancorp (EGBN) came out with a quarterly loss of $2.3 per share versus the Zacks Consensus Estimate of $0.4. This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -675.00%. A quarter ago, it was expected that this bank holding company would post earnings of $0.46 per share when it actually produced earnings of $0.06, delivering a surprise of -86.96%. Empirical research shows a strong correla ...
Annaly Capital Management (NLY) Tops Q2 Earnings Estimates
ZACKS· 2025-07-23 22:31
Annaly Capital Management (NLY) came out with quarterly earnings of $0.73 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.68 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.39%. A quarter ago, it was expected that this real estate investment trust would post earnings of $0.71 per share when it actually produced earnings of $0.72, delivering a surprise of +1.41%.Over the la ...
First Busey (BUSE) Q2 Earnings and Revenues Top Estimates
ZACKS· 2025-07-22 23:15
Group 1 - First Busey reported quarterly earnings of $0.63 per share, exceeding the Zacks Consensus Estimate of $0.61 per share, and up from $0.50 per share a year ago, representing an earnings surprise of +3.28% [1] - The company posted revenues of $198.05 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.10%, compared to year-ago revenues of $116.24 million [2] - First Busey has surpassed consensus EPS estimates four times over the last four quarters and topped consensus revenue estimates three times during the same period [2] Group 2 - The stock's immediate price movement will depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] - First Busey shares have increased by approximately 2.4% since the beginning of the year, while the S&P 500 has gained 7.2% [3] - The current consensus EPS estimate for the upcoming quarter is $0.62 on revenues of $195.9 million, and for the current fiscal year, it is $2.49 on revenues of $728.85 million [7] Group 3 - The Zacks Industry Rank for Banks - Midwest is currently in the top 31% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for First Busey was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6]
Beyond (BYON) Moves 22.5% Higher: Will This Strength Last?
ZACKS· 2025-07-22 12:45
Company Overview - Beyond (BYON) shares increased by 22.5% to $10.84 in the last trading session, with a notable trading volume, and have gained 47% over the past four weeks [1] - The company is benefiting from the resurgence of the Overstock.com brand, a reimagined Bed Bath & Beyond with significant SKU reduction, and the acquisition of buybuy BABY [2] Financial Performance - Beyond is expected to report a quarterly loss of $0.37 per share, reflecting a year-over-year change of +51.3%, with revenues projected at $261.38 million, down 34.3% from the previous year [3] - The consensus EPS estimate for Beyond has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Beyond operates within the Zacks Internet - Commerce industry, where eBay (EBAY) also operates, finishing the last trading session 1.1% higher at $79.03, with a 0.7% return over the past month [4] - eBay's consensus EPS estimate for its upcoming report is $1.3, representing a +10.2% change from the previous year, and it currently holds a Zacks Rank of 2 (Buy) [5]
atai Life Sciences (ATAI) Upgraded to Strong Buy: Here's Why
ZACKS· 2025-07-21 17:01
Core Viewpoint - atai Life Sciences N.V. (ATAI) has been upgraded to a Zacks Rank 1 (Strong Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system emphasizes the importance of changing earnings estimates, which are closely correlated with near-term stock price movements [4][6]. - Rising earnings estimates for atai Life Sciences indicate an improvement in the company's underlying business, likely leading to an increase in stock price [5][10]. Zacks Rating System - The Zacks Rank stock-rating system categorizes stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7][9]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions [9][10]. Recent Earnings Estimate Revisions - For the fiscal year ending December 2025, atai Life Sciences is expected to earn -$0.54 per share, unchanged from the previous year [8]. - Over the past three months, the Zacks Consensus Estimate for atai Life Sciences has increased by 27.9% [8].
PepsiCo (PEP) Q2 Earnings and Revenues Top Estimates
ZACKS· 2025-07-17 14:51
分组1 - PepsiCo reported quarterly earnings of $2.12 per share, exceeding the Zacks Consensus Estimate of $2.03 per share, but down from $2.28 per share a year ago, representing an earnings surprise of +4.43% [1] - The company posted revenues of $22.73 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.51% and showing an increase from $22.5 billion year-over-year [2] - Over the last four quarters, PepsiCo has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] 分组2 - The stock has underperformed the market, losing about 11% since the beginning of the year compared to the S&P 500's gain of 6.5% [3] - The current consensus EPS estimate for the coming quarter is $2.35 on revenues of $23.63 billion, and for the current fiscal year, it is $7.87 on revenues of $92.47 billion [7] - The Zacks Industry Rank for Beverages - Soft drinks is currently in the top 33% of over 250 Zacks industries, indicating a favorable outlook for the industry [8] 分组3 - Ahead of the earnings release, the estimate revisions trend for PepsiCo was mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - Another company in the same industry, Vita Coco Company, Inc., is expected to report quarterly earnings of $0.37 per share, reflecting a year-over-year change of +15.6% [9]
Hilton Worldwide (HLT) Moves 3.1% Higher: Will This Strength Last?
ZACKS· 2025-06-30 15:15
Core Viewpoint - Hilton Worldwide Holdings Inc. (HLT) shares experienced a 3.1% increase, reflecting strong demand in the hospitality sector and positive investor sentiment driven by earnings growth expectations [1][2]. Company Performance - HLT shares closed at $265.5, with a notable trading volume that exceeded the average [1]. - The stock has gained 3.7% over the past four weeks, indicating a positive trend [1]. Revenue and Earnings Expectations - The company is projected to report quarterly earnings of $2.01 per share, representing a year-over-year increase of 5.2% [3]. - Expected revenues for the upcoming quarter are $3.07 billion, which is a 3.9% increase compared to the same quarter last year [3]. Analyst Sentiment - Analysts have slightly revised the consensus EPS estimate higher over the last 30 days, which typically correlates with stock price appreciation [4]. - Positive trends in earnings estimate revisions are expected to support further price strength for HLT [4]. Industry Context - Hilton Worldwide is part of the Zacks Hotels and Motels industry, which is currently experiencing strong demand across leisure, business, and group travel segments [2]. - Another company in the same industry, Choice Hotels (CHH), also showed a positive performance, closing 0.7% higher [5].
Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?
ZACKS· 2025-06-25 13:00
Company Overview - Outset Medical, Inc. (OM) shares increased by 15% to close at $19.97, with trading volume significantly higher than usual, contrasting with a 3.2% loss over the past four weeks [1][2] Financial Performance - The company reported strong financial results for Q1 2025, driven by optimism regarding its expanding installed base and recurring revenue potential from the Tablo dialysis system [2] - Outset Medical is expected to report a quarterly loss of $1.76 per share, reflecting a year-over-year change of +75%, with revenues projected at $29.77 million, an increase of 8.7% from the previous year [3] Earnings Estimates and Stock Movement - The consensus EPS estimate for Outset Medical has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [4] Industry Context - Outset Medical is part of the Zacks Medical Info Systems industry, which includes other companies like Senseonics Holdings (SENS), which saw a 1.2% increase in its last trading session [4] - Senseonics has a consensus EPS estimate of -$0.02, representing a year-over-year change of +33.3%, and currently holds a Zacks Rank of 2 (Buy) [5]